Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma
Metrics: PDF 1438 views | HTML 2076 views | ?
Graeme Cowan1,*, Nicola J. Weston-Bell2,*, Dean Bryant2, Anja Seckinger3, Dirk Hose3, Niklas Zojer4, Surinder S. Sahota2
1Institute of Immunology and Infection Research, Centre for Immunity, Infection and Evolution, University of Edinburgh, UK
2Tumour Immunogenetics Group, Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, UK
3Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany
4Center for Oncology and Hematology, 1st Department of Medicine, Wilhelminenspital, Vienna, Austria
*These authors have contributed equally to this work
Surinder S. Sahota, e-mail: email@example.com
Keywords: multiple myeloma, pathogenesis, IGHV genes, germinal center
Received: February 10, 2015 Accepted: March 24, 2015 Published: April 10, 2015
Human multiple myeloma (MM) is characterized by accumulation of malignant terminally differentiated plasma cells (PCs) in the bone marrow (BM), raising the question when during maturation neoplastic transformation begins. Immunoglobulin IGHV genes carry imprints of clonal tumor history, delineating somatic hypermutation (SHM) events that generally occur in the germinal center (GC). Here, we examine MM-derived IGHV genes using massive parallel deep sequencing, comparing them with profiles in normal BM PCs. In 4/4 presentation IgG MM, monoclonal tumor-derived IGHV sequences revealed significant evidence for intraclonal variation (ICV) in mutation patterns. IGHV sequences of 2/2 normal PC IgG populations revealed dominant oligoclonal expansions, each expansion also displaying mutational ICV. Clonal expansions in MM and in normal BM PCs reveal common IGHV features. In such MM, the data fit a model of tumor origins in which neoplastic transformation is initiated in a GC B-cell committed to terminal differentiation but still targeted by on-going SHM. Strikingly, the data parallel IGHV clonal sequences in some monoclonal gammopathy of undetermined significance (MGUS) known to display on-going SHM imprints. Since MGUS generally precedes MM, these data suggest origins of MGUS and MM with IGHV gene mutational ICV from the same GC B-cell, arising via a distinctive pathway.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.